
Loading, please wait...

Loading, please wait...

Mitochondria are essential for energy production. However, they lack standard nucleotide excision repair mechanisms. Surprisingly, mitochondrial DNA (mtDNA) remains resistant to mutation accumulation after damage. Recent research highlights the role of TFAM mtDNA damage sensing in maintaining genome integrity. Scientists investigated how Transcription Factor A, Mitochondrial (TFAM) interacts with DNA after ultraviolet-C (UVC) exposure.
TFAM traditionally compacts mtDNA into nucleoids. New data shows that UVC irradiation reduces its sequence specificity. Consequently, TFAM redistributes throughout the mitochondrial genome. Using atomic force microscopy, researchers observed increased DNA compaction by TFAM when damage is present. Interestingly, this compaction does not directly protect the DNA from forming lesions.
Instead of shielding the DNA, TFAM likely acts as a sensor. It sequesters damaged genomes to prevent them from replicating. This process facilitates the removal of mutated DNA through degradation. Furthermore, cells show increased TFAM mRNA levels following UVC exposure. This suggests a coordinated cellular response to handle irreparable mitochondrial damage. Importantly, these changes occur without triggering mitophagy or losing membrane potential.
In vivo studies demonstrate that TFAM knockdown alters mtDNA damage levels. This underscores its vital role in baseline genomic maintenance. While increased TFAM protein does not shield against initial damage, it aids in managing the aftermath. By compacting the damaged areas, TFAM effectively "tags" the genome. This tagging prevents the replication of faulty genetic information. Ultimately, this mechanism preserves the overall health of the mitochondrial population.
TFAM reduces its sequence specificity and redistributes across the mitochondrial genome. It then increases the compaction of the damaged DNA to sequester it.
No, research indicates that TFAM does not prevent damage formation. Instead, it likely tags or sequesters damaged genomes to prevent mutagenesis during replication.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
1. King DE et al. UV irradiation alters TFAM binding specificity and compaction of DNA. Elife. 2026 Mar 25. doi: undefined. PMID: 41879805.
2. Chen YH, Zhao L. Mitochondrial DNA Damage and Repair: Insights Into TFAM Binding, Glutathionylation, and Chemical Manipulation. eScholarship. 2024.
3. Song Y. The Protective Mechanism of TFAM on Mitochondrial DNA and its Role in Neurodegenerative Diseases. PubMed. 2023.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research reveals that TFAM acts as a sensor for mitochondrial DNA damage by compacting damaged genomes, helping to prevent the spread of mutations....
6 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today